FREE L-GLUTAMATE (GLU) IN breast milk is ϳ30 -40 higher than that in plasma in humans (1, 24, 35) and ϳ10 times higher in rats (5) (milk data not shown). In fact, Glu is the most abundant amino acid (both free and peptide-bound) in milk (8, 29) , suggesting an active synthesis of Glu in mammary tissue. As a free amino acid, Glu belongs to the nonprotein nitrogen fraction of milk, which contributes to the total available nitrogen in suckling neonates and is a major source of energy for their gut mucosa (1, 7, 25) . Newborn pigs and rats already express Glu transporters at the brush border membrane of enterocytes, the excitatory amino acid carrier 1 (EAAC-1; Refs. 10, 27) , where Glu undergoes transamination and oxidative metabolism (7) . These are important steps for ATP production that is required for the absorption of nutrients. Free Glu is also a cue for umami taste, which can influence the acceptance of new food in infants (30) . It has been known for more than 20 yr that naive neonates, 1-4 h after birth, respond with stereotypical facial expressions considered as positive hedonic reactions to the taste of a vegetable broth with 0.5% monosodium glutamate (34) . Thus babies are born with the ability to perceive and like the taste of free Glu in milk, which may play a role in the acceptance of a high variety of new foods (18) .
Our knowledge regarding the process by which the mammary gland concentrates free Glu is limited. Recently, it has been shown that during lactation the mammary gland takes up large amounts of branched-chain amino acids (BCAA), L-leucine (Leu), L-isoleucine (Ile), and L-valine (Val) and extensively degrades them for the synthesis of Glu, L-glutamine (Gln), L-aspartate (Asp), L-asparagine (Asn), and L-alanine (Ala; Ref. 17) . In fact, lactating sows require high amounts of BCAA to support the production of milk (17) . The catabolism of BCAA consists on two catalytic steps: transamination catalyzed by BCAA aminotransferase (BCAT) to form the branched-chain ␣-ketoacid (BCKA), and the irreversible oxidative decarboxylation of BCKA by the mitochondrial BCKA dehydrogenase (BCKAD) enzyme complex. The transamination reaction results in the net transfer of nitrogen from BCAA to dispensable amino acids such as Glu, and this process is hormonally regulated. Insulin and growth hormone inhibit BCAA transamination, whereas cortisol and glucagon increase it (9, 15, 17) . This high BCAA demand suggests active BCAA transport in mammary cells. Shennan et al. (32) have shown that the mammary gland possesses amino acid transport systems at the basolateral membrane that are similar to those of other organs. Among those amino acid transport systems, mammary cells express two L-system transporters, which are Na independent and sensitive to 2-aminobicyclo-[2.2.1]-heptane-2-carboxylic acid (BCH) inhibition and the solute carrier transport (SLC) SLC7A5 (LAT1) and SLC7A8 (LAT2) (31) . Based on a paired-tracer dilution technique to analyze the flux and clearance of amino acids in the lactating rat mammary gland, it was suggested that system L contributed significantly to the uptake of Leu. Surprisingly, there has been no further analysis on the relevant L-amino acid transport system in the mammary gland and its relation with free Glu secretion in milk. In this study, using isolated mammary cells, organ culture, and lactating rats, we provide further insights on the Leu transport biology of the mammary tissue and its role in the production of nonessential amino acids during lactation.
MATERIALS AND METHODS

Chemical reagents. L-[
3 H]leucine was purchased from Dai-Ichi Clarity L-[
15 N]leucine was purchased from Cambridge Isotope Laboratories, Other reagents were purchased from Sigma-Aldrich.
Animals. All experimental procedures were approved by the Institute of Life Sciences Animal Care and Use Committee and conformed to the standards for the use of laboratory animals published by the Institute of Laboratory Animal Resources, US National Academy of Sciences. Female Sprague-Dawley rats with a mean weight of 200 -300 g were obtained from Charles River Japan. Animals were housed in a controlled 12:12-h light-dark photoperiod and had free access to food (CRF-1; Oriental Yeast) and drinking water until the beginning of the experiment. The vivarium was maintained at constant temperature and humidity (23 Ϯ 1, 50 -60%). After normal pregnancy and delivery, the litter size was adjusted to eight pups per dam. Nonpregnant and nonlactating rats are considered "virgin rats."
RNA extraction. Total RNA was isolated from rat mammary gland and mammary cells using an RNA preparation kit (Isogen; Nippongene) following the manufacturer's instructions. Subsequently, cDNA was synthesized from RNA using SuperScript Reverse Transcriptase III (Invitrogen). The PCR products were separated by electrophoresis on agarose gels and visualized by ethidium bromide staining with ultraviolet light illumination.
Real-time quantitative RT-PCR. cDNAs for target genes were quantified by real-time amplifications in the Applied Biosystems Step One Plus Real-Time PCR system (Foster City, CA) that utilized the Fast SYBR Green Master mix. cDNAs were amplified by 40 cycles (see Table 1 for primers).
Isolation of mammary cells. Epithelial cells were isolated from the whole mammary glands of lactating Sprague-Dawley rats by enzymatic digestion on day 18 postpartum and were purified on a Percoll density gradient, as previously reported (11) . Briefly, minced mammary glands were suspended in medium 199 (Nissui Pharmaceutical) containing 100 IU/ml penicillin and 100 g/ml streptomycin (Invitrogen), 6.6% FBS (Invitrogen), 300 U/ml type I collagenase (Worthington), and 500 U/ml type I hyaluronidase (Sigma-Aldrich) at 32°C for 3 h. After being washed in medium 199 containing FBS, the preparations were further incubated with 0.02% deoxyribonuclease I (Sigma-Aldrich) for 10 min, filtered through a 150-m mesh (Swiss Silk Bolting Cloth), and further incubated with 700 U/ml pronase (Calbiochem) for 10 min. Dispersed mammary fragments were centrifuged through a preformed 42% Percoll isopycnic density gradient. Epithelial cells recovered from the percoll density fraction Ͼ1.055 g/ml were resuspended in DMEM-F-12 (1:1) (Invitrogen) supplemented with 5% FBS.
Transport assay. Mammary cells were suspended in transport assay medium (125 mM NaCl, 4.8 mM KCl, 5.6 mM D-glucose, 1.2 mM CaCl 2, 1.2 mM KH2PO4, 1.2 mM MgSO4, and 25 mM HEPES, pH 7.4). The cells were incubated at 37°C for 3 min; the transport assay was initiated by addition of 50 M radiolabeled Leu (5 kBq/assay; PerkinElmer Life Science) as described previously (21) . At appropriate times, aliquots of the mixture (200 l) were filtered through 0.45-m type HA membrane filters (Millipore). Each filter was washed with 5 ml of ice-cold medium, and the radioactivity remaining on the filter was counted. Amounts of Leu taken up by the cells are expressed as picomoles per 10 6 cells. Incubation of mammary tissue. Incubations were performed in 5-ml test tubes placed in a water bath. Mammary tissue slices (ϳ100 mg) were incubated at 37°C for 3 h in 1 ml incubation buffer (122 mM NaCl, 25 mM NaHCO 3, 5 mM KCl, 20 mM D-glucose, 1.5 mM CaCl2, 1.3 mM MgSO4, and 15 mM HEPES, pH 7.4 saturated with 100%O2) with or without 2 mM Leu.
Oral administration of Leu. Rats were deprived of food for 3 h and then randomly assigned to receive oral administration of vehicle or 1 g/kg Leu. Administered Leu was prepared as 200 g/l in 0.5% methylcellulose (1.5 ml/300 g rat weight). Exactly 2 h after oral gavage, milk was collected from the rats by mild suction while the animals were under 2% isoflurane anesthesia (Mylan). Oxytocin (0.5 units/kg; Takeda Pharmaceutical) was administered intraperitoneally to rats before milking. Blood was collected from the vein tail, and all samples were stored frozen (Ϫ80°C) until analysis.
Determination of free amino acids.
To analyze the content of free amino acids in milk, proteins were precipitated by mixing well 500 l of rat milk with 1 ml of sulfosalicylic acid (6%) before centrifugation (4°C, 15 min, 1,200 g). The supernatant fluid was purified by filtering first with a 0.45-m filter, followed by an Amicon Ultra centrifugal filter (Millipore, Tokyo, Japan) to remove molecules Ͼ10 kDa. Amino acids in the samples were determined in duplicates using an automatic amino acid analyzer (model L-8,900; Hitachi, Tokyo, Japan) that involved postcolumn reactions with the ninhydrin reagent (22) . Data represent the average of two measurements with final adjustment by the one-third dilution.
Determination of isotopic enrichment. Isotopic enrichments of amino acids in plasma and milk were analyzed by GC/MS. The PCA extracts of plasma and milk were neutralized with K 2CO3 and centrifuged, and the supernatant fluid was brought to pH 4 -6 with 1 M acetic acid. The specimens were applied to a 1-ml bed volume cation exchange column (Dowex 50W ϫ 8, H ϩ form: Bio-Rad, Hercules, CA). The amino acids were eluted with 3 M ammonia solution and dried under a vacuum. The dried samples were dissolved in water, adjusted to pH 8 by addition of ammonia solution, and applied to an anion exchange column (Dowex 1 ϫ 8, Cl Ϫ form; Bio-Rad). Neutral amino acids including glutamine were collected as the pass through Sequence of the forward (F) and reverse (R) primers of indicated genes with their corresponding GeneBank accession numbers, melting temperature (Tm), and size of the amplified template (right). fraction, and glutamate and aspartate were eluted with 1 M acetic acid according to the methods described previously (23) . The specimens were dried and the n-propyl esters of the heptaflurobutyramides were prepared as reported previously (12) . Briefly, the carboxyl moieties were esterified by 1-propanol at 80°C for 30 min in the presence of acetyl chloride, and the amino and amide moieties were derivatized with heptafluorobutyric anhydride at 60°C for 20 min. Each amino acid was separated by gas chromatography (6890N; Agilent Technologies, Waldbrunn, Germany) equipped with an HP-5 column (Hewlett Packard), and the isotopic distribution was analyzed with mass spectrometry (5073N; Agilent Technologies). Negative ions generated by methane chemical ionization were analyzed by selected ion monitoring. The monitored ions were glutamate (407, 408), aspartate (393, 394), leucine (349 -355), and alanine (307 308). For the determination of [2- 15 N]glutamine enrichment, its deamidated product, the same derivative as that of glutamate, was analyzed by monitoring ions at m/z 407 and 408. After adjustment for the baseline enrichment of the [M ϩ 1] signal of natural standards, the isotopic enrichment of 15 N-containing compounds was expressed as molar percent excess (MPE, mol%). This was calculated from the tracer/tracee ratio (TTR; mol%) as MPE ϭ TTR/(TTR ϩ 1).
Statistical analysis. Data are expressed as means Ϯ SD. Results were analyzed by Student's t-test, and differences with a P Ͻ0.05 were considered significant.
RESULTS
Detection of system L transporters in rat mammary tissue.
The expression of the mRNA for LAT1, LAT2, and its associating protein SLC3A2 (4F2hc) in rat mammary tissues was detected by RT-PCR (Fig. 1A) . The mRNA for other amino acid transporters SLC6A14, SLC6A19, SLC7A6, and SLC7A7 was not observed in mammary tissue (Fig. 1A) .
To clarify which Leu transporter is the major one, the relative expression of LAT1 and LAT2 in mammary tissue was further investigated by real-time PCR (qRT-PCR). Results indicated that the amount of LAT1 was sixfold higher than that of LAT2 in the mammary gland (Fig. 1B) . Consistent with results from the RT-PCR analysis (Fig. 1A) , SLC6A14, SLC6A19, SLC7A6, and SLC7A7 were not detected in mammary tissue using qRT-PCR (data not shown).
Characterization of system L transporters in isolated rat mammary cells. We confirmed the characterization of the cells by the expression of mRNA for the whey acidic protein, which is a specific marker of mammary epithelial cells. Consistent with initial results, LAT1, LAT2, and 4F2hc were detected in mammary cells. By qRT-PCR, the amount of LAT1 was found to be about fivefold higher than the level of LAT2 in mammary cells (Fig. 2B) .
To determine which transporter was the most relevant, we also examined the properties of [ 3 H]Leu uptake by rat mammary cells. The rate of [ 3 H]Leu (50 M) transport in mammary cells was not affected by replacing NaCl in the transport medium with choline-Cl (Fig. 3A) . This suggests that the uptake of Leu in mammary cells is virtually Na ϩ independent. Thus transport activity assays in subsequent experiments were conducted under Na ϩ -free conditions. As shown in Fig. 3B , Leu uptake was strongly inhibited by 5 mM BCH, which is a specific inhibitor of system L transporters.
Isolated mammary cells exhibited a time-dependent Leu transport activity, and the transport was linear for up to 5-min incubation (Fig. 4A) . Therefore, we performed following transport measurements for 3 min and expressed values as picomoles per 10 6 cells per minute. As shown in Fig. 4B , the transport activity of mammary cells was saturable with respect to substrate concentration, and K m and V max values for Leu were 81 M and 56 pmol/10 6 cells/min, respectively (Fig. 4B) .
Inhibition of L-[
3 H]Leu uptake by other amino acids and transporter inhibitors. Next, competitive assays with potential transporter substrates and Leu were used on rat mammary cells. The substrate specificity of LAT1 is different from that of LAT2 in regard to some amino acids like L-glycine (Gly), L-alanine (Ala), L-serine (Ser), L-threonine (Thr), and L-cysteine (Cys). Thus the uptake of (Fig. 5A ). As shown in Fig. 5B , Leu uptake was largely inhibited by 50 M triiodothyronine (T 3 ), which is a specific inhibitor for LAT1.
Glu release in mammary tissue. To investigate whether LAT1 is involved in Glu release, we incubated mammary tissue for 3 h in the presence of 2 mM Leu with or without a LAT1 inhibitor (Fig. 6 ). Glu concentration in the absence of Leu was the control. When Leu was present, the concentration of Glu was about twofold higher than the control. And the increase of Glu concentration was time dependent and linear up to a 3-h incubation (data not shown). BCH and T 3 decreased Glu concentration in the presence of Leu, whereas BCH and T 3 had no effect on Glu concentration when Leu was absent.
Effect of oral Leu administration on Glu concentration in rat milk. Leu (1 g/kg body wt) was orally administered to rats at 6, 12, and 18 days of lactation to study its effect on the concentration of Glu in milk. The concentration of Leu in plasma after Leu administration increased about two-to fourfold compared with the control on each lactation day (Table 2) . Similarly, the concentration of Leu in milk after Leu administration increased about three-to sevenfold compared with the control on each lactation day ( Table 2 ). The concentration of Glu in plasma 3 H]leucine uptake by isolated mammary cells using a transport medium (Na ϩ ) or a Na ϩ free transport medium (choline) in the absence (control) or presence of free leucine (5 mM). B: effect of the specific system L inihibitor 2-aminobicyclo-[2.2.1]-heptane-2-carboxylic acid (BCH; 5 mM) to [ was comparable with the levels of the control, whereas Glu in the milk increased about twofold compared with the control (Fig. 7, A and B) . Asp concentration in milk increased in a similar manner to Glu (Fig. 7, C and D) . Both Glu and Asp concentration in milk augmented progressively throughout lactation (Fig. 7) .
N labeling of amino acids after oral [ N]Leu administration. To examine how Leu is metabolized into Glu, we administered 1 g/kg [
15 N]Leu in rats on day 18 of lactation. The proportion of labeled Leu and Glu in plasma was 27.5 Ϯ 3.0 and 10.7 Ϯ 1.7% (Table 3) , whereas the proportion of labeled Leu and Glu in milk was 28.2 Ϯ 0.7 and 15.0 Ϯ 1.2%, respectively. Other amino acids related to Glu metabolism, Gln, Ala, and Asp, were 12.2 Ϯ 2.7, 14.4 Ϯ 2.6, and 6.8 Ϯ 1.6% in plasma and 13.0 Ϯ 4.5, 10.5 Ϯ 3.5, and 12.5 Ϯ 3.3% in milk.
DISCUSSION
The lactating mammary tissue selectively synthesizes Glu, mostly through transamination, not only for protein synthesis but also for the free amino acid pool in milk where Glu is the predominant amino acid (8, 17, 29) . Recent studies have shown that BCAA are the major amino acids for the production of Glu, Gln, and Asp (17) . Considering Leu as the prototype amino acid for BCAA, its transportation is the first and limiting step for Leu utilization in mammary epithelial cells. By using cell lines such as HC11 (mouse mammary epithelial) or Mac-T (bovine mammary epithelial) cells, recent studies have shown that the uptake and transamination of Leu increase with increasing extracellular concentrations from 0.25 to 2 mmol/l in a dosedependent manner (16) . Thus we have used in mammary tissue experiments 2 mM Leu to ensure that concentration was not a limiting factor for Leu transportation into cells. Several amino acid transporters have been described at the basolateral membrane of mammary cells (32) . Among them, two possible L-system transporters, LAT1 and LAT2, have been proposed to be involved in Leu uptake in the mammary gland (31) . LAT1 and LAT2 are light chains that associates with the 4F2hc heavy chain to form the L-type heterodimeric amino acid transporters 1 and 2 (38) . We have verified with RT-PCR analysis that mammary glands and isolated cells express LAT1, LAT2, and 4F2hc (Fig. 1A) . No other Leu transporter was observed either in tissue or cells. With qRT-PCR, we could confirm that during lactation the expression of LAT1 was greater than that of LAT2 in both tissue and cells (Fig. 1B) , whereas in the glands of virgin rats was similar (data not shown). These results indicate that LAT1, which functions together with 4F2hc (14) , is most abundant than LAT2 and specific to the lactation period. This expression pattern for LAT1 is similar to the one reported previously by Aleman et al. (3) in rats and Manjarin et al. (20) in pigs and probably respond to the specific hormonal changes that occur during pregnancy and lactation. Recent studies have shown that Leu transamination and decarboxylation are stimulated by cortisol in rat mammary tissue and the glucocorticoid receptor NR3C1 curiously overlaps with the expression of the major milk proteins ␣-lactalbumin and ␤-casein in the porcine mammary gland (15, 19) . In contrast, the expression of the growth hormone receptor (growth hormone inhibits Leu transamination) tended to decreases with lactation. Leu also activates protein synthesis through stimulation of the mammalian target of rapamycin (mTOR) signaling pathway (4). Therefore, the increase of Glu production in mammary tissue throughout lactation could be partly explained by the effect of glucocorticoids on Leu transamination or by the increase of Leu transport and transamination enzyme synthesis after mTOR activation. We still need to evaluate whether the function or transcription of Leu transporters is upregulated by mTOR or the same hormones that modulate Leu metabolism.
To corroborate whether the function of mammary tissue transporters corresponded to the L system, we used the [ 3 H]Leu tracer. As Shennan et al. (31) observed with perfused rat mammary glands, the Leu transporters in mammary epithelial cells and lactating mammary tissue are Na independent and mostly inhibited by BCH (Fig. 3) . Moreover, the uptake of [ 3 H]Leu in mammary cells followed the Michaelis-Menten kinetics (Fig. 4B ) and was saturable, and its K m value (81 M) similar to the one reported in human bladder carcinoma cells (T24 cells), which also express both LAT1 and 4F2hc (14) . To further corroborate the function of the Leu transporter in mammary tissue, we performed a competitive assay with other amino acids. The [ 3 H]Leu uptake was highly inhibited by Cys, Ser, and Thr (Fig. 5A) , supporting an important role for the transport of Leu by the L system in mammary cells. In regard to the inhibition of Leu uptake by BCH, although this compound is the most selective inhibitor of system L, the effect of BCH is not restricted to system L. BCH also inhibits the Na-dependent systems Bo, ATB 0,ϩ , and B 0 AT1 (6, 33) . The potential role of these transporters was clarified by using mammary cells in Na-free medium. Under this condition, BCH still could inhibit Leu uptake. Furthermore, T 3 that is a specific inhibitor for LAT1 (36, 40) also blocked Leu uptake in mammary cells. In the presence of 50 M T 3, the transport of Leu was reduced by 60% compared with the control. The rest of Leu uptake may result from the action of LAT2. Collectively, these results indicate that there are two L-system transporters expressed in mammary cells LAT1 and LAT2, with the amount of LAT1 being higher than that of LAT2. Moreover, the inhibitory properties of amino acids for the uptake of [ 3 H]Leu in mammary cells were comparable to those for rat LAT1 expressed in Xenopus oocyte (13) . Taking these data into consideration, we conclude that LAT1 is the main Leu transporter in rat lactating mammary gland.
Previous studies have shown that the mammary gland of sows takes up large amounts of BCAA from plasma (e.g. Control ( Values correspond to the means Ϯ SD for n ϭ 9 -12. Rats received 1 g/kg of leucine (Leu) and measurements were made 2 h after the gavage at 6, 12, and 18 days postpartum. BCAA, branched-chain amino acid. *P Ͻ 0.05. synthesis of Glu, Gln, Asp, Asn, and Ala (17) . Glu is significant in milk because it is the most abundant amino acid in the free amino acid pool. It is important for the synthesis of glutathione and growth, development, and function of the neonatal gastrointestinal tract (26, 39) . Newborn pigs and rats already express Glu transporters at the brush border membrane of enterocytes, the EAAC-1 (10, 27) , where Glu undergoes transamination and oxidative metabolism (7). It is also known that free Glu enhances the mucosal defense systems (2) through Glu sensors in the gastrointestinal mucosa (GI) of rats and can spare glutamine oxidation by gut mucosa, which functions as precursor for the synthesis of purines pyrimidines and amino sugars (16, 28) . The amount of Gln found in sow's milk seems insufficient for maximal growth of piglets (12, 16) . Some of these physiological responses to luminal Glu in the GI seem to be mediated by the vagus nerve after the release of nitric oxide and 5-hydroxytryptamine (37 (Table 3 and Fig. 8) , that the secretion of Glu by mammary epithelial cells augmented by the addition of 2 mM Leu (Fig. 6) , and that this increase was inhibited by BCH and T 3 , inhibitors of LAT1 (Fig. 6 ). In addition, the oral administration of 1 g/kg Leu to rats at 6, 12, and 18 days of lactation increased the concentration of Glu, Asp, and Leu in milk (Table 2 and Fig. 7) . These metabolic and isotopic data demonstrate that Glu and Asp are the major nitrogenous products of Leu catabolism in lactating rat mammary tissue. Therefore, the production of these two amino acids seems dependent on the availability of BCAA and the activity of LAT1 and LAT2 transporters.
In conclusion, we identified LAT1 as the major Leu transporter in mammary tissue. This transporter facilitates the metabolism of Leu in lactating mammary tissue, thereby contributing to the production of Glu and Asp in milk. Thus dietary Leu supports the synthesis of Glu for milk production. Also, Values correspond to the means Ϯ SD for n ϭ 3. Leu transport system linked to BCAA catabolic pathways in the mammary gland during lactation. This biological mechanism induces the synthesis of glutamate that either is used to produce milk proteins or be secreted free into milk. ␣-KG, ␣-ketoglutarate; BCAT, BCAA aminotransferase; BCK, branched-chain ketoacid; BCKD, BCK dehydrogenase; GOT, glutamate-oxaloacetate transaminase; GS, glutamine synthase.
higher free Glu in milk may contribute not only to the umami taste sensation but also may serve as a signal to improve milk protein digestion and amino acid absorption for the growth support of the neonate.
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